The HPV Puzzle: Quest to Deintensify Therapy in Oropharyngeal Cancer Continues

Meir Rinde
Published: Monday, Nov 05, 2018
Nabil F. Saba, MD
Nabil F. Saba, MD
After more than 2 decades of change in the epidemiology of oropharyngeal cancers, the choice of optimal treatment for patients with human papillomavirus (HPV)–positive disease remains elusive. Investigators are testing strategies that could reduce the intensity of treatment for patients who are HPV positive and lessen the often serious long-term adverse events (AEs) while maintaining efficacy.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: How Can We Optimize Outcomes in Head and Neck Cancers with Immunotherapeutic Strategies?Oct 31, 20191.5
Publication Bottom Border
Border Publication